Meaningful Use Stage 3: a detailed timeline
By now, most providers are well acquainted with the Meaningful Use Stage 1 or Stage 2 criteria and implementation timeline. Just as stage 1 and 2 were becoming a newly acquired comfort zone for the healthcare industry Stage 3 Meaningful Use has entered the picture.
The proposed meaningful use Stage 3 rule issued on 03/30/15 by Centers for Medicare and Medicaid Services (CMS) attempts to streamline standards and offer providers more flexibility concerning regulatory compliance. With the impending implementation of Stage 3 what can providers expect concerning changes from Stage 2 regulations and timeline.
GET EHR RESEARCH & KNOWLEDGE RIGHT TO YOUR INBOX
Covering the key issues faced by businesses selecting and implementing EHR.
Stage 3 Meaningful Use Timeline
2017: The EHR reporting period (regardless of MU status) will be a full 365 days.
2017: The reporting period for quality reporting will shift to 365 days.
2017: Hospitals and EPs in their first year of MU, will no longer be required to use the 90-day reporting option, instead shifting to the 365-day reporting period.
2017: Any hospital or EP will have the option of attesting to Stage 3 in 2017.
2017: Providers have the choice of attesting to the same MU stage that they attested to in 2016. A provider attesting to Stage 2 in 2016 will be limited to Stage 2 and Stage 3 in 2017.
2018: All hospitals and EPs will be required to adopt Stage 3 regardless of prior participation or where they currently are in the program. Stage 1 and Stage 2 would become obsolete in 2018.
2018: 2015 Edition CEHRT would be required.
2018: CQMs should be reported electronically “where feasible.”
Stage 3 Meaningful Use Changes
CPOE: Under Stage 2, 60% of prescription orders, 30% of lab orders, and 30% of radiology orders were required to be CPOE. Under Stage 3 80% of prescription orders, 60% of lab orders, and 60% of diagnostic imaging orders in Stage 3.
Patient Engagement: Under Stage 3 meaningful use, providers are required to engage 25% of unique patients with the information in their EHR.
Summary of Care Record: Departing from Stage 2, Stage 3 enacts a new transitions of care measure requiring a summary of care record to be electronically transmitted to 50% of transitions of care this departs from the 40% threshold of Stage 2.
Clinical Decision Support: Under Stage 3, providers must implement five clinical decision support interventions related to 4 or more clinical quality measures at a relevant point inpatient care for the entire EHR reporting period. In the absence of four clinical quality measures related to a provider’s scope of practice or patient population, the clinical decision support interventions must be linked to high-priority health conditions. Further a provider must have enabled and implemented the functionality for drug-drug and drug-allergy interaction checks for the entire EHR reporting period.
Given these changes, one is struck with the impression that this may very well be a difficult transition. The government has taken steps to simplify the regulations related to Meaningful Use.
However, it is apparent that there is a strong expectation that providers will need to be well on their way to using advanced EHR technology by 2018. The next few years will likely be a fluid period in the healthcare industry and the EHR technology industry as this shift towards stage 3 meaningful use occurs.
Meaningful Use over the next two years: what to expect
How Meaningful Use will evolve, and what you can do to prepare
Not up to scratch on Meaningful Use? Here’s where to start
Hospitals that are not meaningfully using EHR will be hit by payment adjustment this October
How to conduct a thorough EHR audit
When to conduct an EHR audit, and what your practice should bear in mind whilst doing so